Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tamar Tadmor

Showing results (1-10 of 211) with videos related to

Pageof 22
Sort By:
Acta Haematologica|February 26, 2019
Time to Understand More about Spontaneous Regression of CancerTamar Tadmor
The Lancet. Haematology|July 21, 2024
Overcoming the unmet need of Richter transformation: the use of pirtobrutinibTamar Tadmor
Leukemia & Lymphoma|October 30, 2012
Free light chain assay: doing a "good job" in Job's syndromeTamar Tadmor
Leukemia & Lymphoma|April 6, 2011
Purine analog toxicity in patients with hairy cell leukemiaTamar Tadmor
Harefuah|May 29, 2017
[INTEGRATIVE MEDICINE AND CHRONIC LYMPHOCYTIC LEUKEMIA]Tamar Tadmor
Leukemia & Lymphoma|April 11, 2014
The growing link between multiple myeloma and myeloid derived suppressor cellsTamar Tadmor
Leukemia Research|August 20, 2013
Does monocyte count have prognostic significance in cancer?Tamar Tadmor
Haematologica|July 9, 2026
A ray of hope for early-stage T-cell lymphomaTamar Tadmor
Leukemia & Lymphoma|May 24, 2011
Alemtuzumab (Campath-1H) for chronic lymphocytic leukemia: a drug in search of its optimal scheduleTamar Tadmor
Leukemia & Lymphoma|January 8, 2015
Do lymphocytes count in myeloma? Are we absolutely sure?Tamar Tadmor
Pageof 22

Showing results (1-10 of 211) with videos related to

Sort By:
Pageof 22
Acta Haematologica|February 26, 2019
Time to Understand More about Spontaneous Regression of CancerTamar Tadmor
The Lancet. Haematology|July 21, 2024
Overcoming the unmet need of Richter transformation: the use of pirtobrutinibTamar Tadmor
Leukemia & Lymphoma|October 30, 2012
Free light chain assay: doing a "good job" in Job's syndromeTamar Tadmor
Leukemia & Lymphoma|April 6, 2011
Purine analog toxicity in patients with hairy cell leukemiaTamar Tadmor
Harefuah|May 29, 2017
[INTEGRATIVE MEDICINE AND CHRONIC LYMPHOCYTIC LEUKEMIA]Tamar Tadmor
Leukemia & Lymphoma|April 11, 2014
The growing link between multiple myeloma and myeloid derived suppressor cellsTamar Tadmor
Leukemia Research|August 20, 2013
Does monocyte count have prognostic significance in cancer?Tamar Tadmor
Haematologica|July 9, 2026
A ray of hope for early-stage T-cell lymphomaTamar Tadmor
Leukemia & Lymphoma|May 24, 2011
Alemtuzumab (Campath-1H) for chronic lymphocytic leukemia: a drug in search of its optimal scheduleTamar Tadmor
Leukemia & Lymphoma|January 8, 2015
Do lymphocytes count in myeloma? Are we absolutely sure?Tamar Tadmor
Pageof 22